Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Oncternal Therapeutics, Inc
The study has been expanded to explore single agent TK216 for longer treatment duration. Approximately 26 patients will be enrolled in this Cohort. Please note: This study has been terminated and is no longer enrolling patients.
Age
8–any
Sex
ALL
Healthy volunteers
Not accepted
